DISCREPANCIES IN THE DEFINITION OF INFLAMMATORY ARTICULAR DISEASE TO DETERMINE THE PREVALENCE OF PSORIATIC ARTHRITIS AFTER APPLYING CASPAR CRITERIA IN PATIENTS WITH CUTANEOUS PSORIASIS

被引:0
|
作者
Fernandez-Sueiro, J. L. [1 ]
Pinto Tasende, J. [1 ]
Pertega Diaz, S. [1 ]
Gonzalez, E. [1 ]
Fernandez Lopez, J. [1 ]
Oreiro Villar, N. [1 ]
de Toro, F. [1 ]
Blanco, F. [1 ]
机构
[1] Complejo Hosp Univ La Coruna, La Coruna, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:574 / 574
页数:1
相关论文
共 49 条
  • [41] Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
    Schreiber, Stefan
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Reich, Kristian
    Deodhar, Atul A.
    McInnes, Iain B.
    Porter, Brian
    Das Gupta, Ayan
    Pricop, Luminita
    Fox, Todd
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (04) : 473 - 479
  • [42] INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS TREATED WITH SECUKINUMAB: POOLED ANALYSIS OF 21 RANDOMISED CONTROLLED PHASE 3/ 4 CLINICAL TRIALS OF PSORIASIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Schreiber, Stefan
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Reich, Kristian
    Deodhar, Atul
    McInnes, Iain B.
    Porter, Brian
    Das Gupta, Ayan
    Pricop, Luminita
    Fox, Todd
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 18 - 18
  • [43] INFLAMMATORY BOWEL DISEASE IN PSORIATIC ARTHRITIS. STUDY OF 306 PATIENTS FROM A SINGLE UNIVERSITARY CENTER. PREVALENCE, CLINICAL FEATURES AND RELATIONSHIP TO BIOLOGIC THERAPY.
    Sanchez-Bilbao, L.
    Martinez-Lopez, D.
    Palmou-Fontana, N.
    Armesto, S.
    Gonzalez-Gay, M. A.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1715 - 1715
  • [44] Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease
    Hren, Mary Grace
    Guenin, Sophie
    Khattri, Saakshi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (01) : 138 - 140
  • [45] Consideration of confounders, accuracy of diagnosis, and disease severity in assessing the risk of inflammatory bowel disease in patients with psoriasis and psoriatic arthritis/ankylosing spondylitis beginning interleukin-7 inhibitor treatment: comment on the article by Penso et al
    Yang, Cheng-Ruei
    Ker, Amy
    Kao, Pei-En
    Wei, James Cheng-Chung
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (03) : 546 - 547
  • [46] NO INCREASED INCIDENCE OF INFLAMMATORY BOWEL DISEASE AMONG SECUKINUMAB-TREATED PATIENTS WITH MODERATE TO SEVERE PSORIASIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS: DATA FROM 14 PHASE 2 AND PHASE 3 CLINICAL STUDIES
    Schreiber, S.
    Sands, B. E.
    Deodhar, A.
    Baeten, D.
    Huang, J.
    Gandhi, K.
    Karyekar, C.
    Fox, T.
    Gaillez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 97 - 98
  • [47] NO INCREASED RISK OF INFLAMMATORY BOWEL DISEASE AMONG SECUKINUMAB-TREATED PATIENTS WITH MODERATE TO SEVERE PSORIASIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS: DATA FROM 14 PHASE 2 AND PHASE 3 CLINICAL STUDIES
    Zochling, J.
    Deodhar, A.
    Schreiber, S.
    Gandhi, K.
    Fox, T.
    Gaillez, C.
    Karyekar, C.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 38 - 39
  • [48] No Increased Risk of Inflammatory Bowel Disease Among Secukinumab-Treated Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis: Data from 14 Phase 2 and Phase 3 Clinical Studies
    Deodhar, Atul A.
    Schreiber, Stefan
    Gandhi, Kunal
    Fox, Todd
    Gaillez, Corine
    Karyekar, Chetan
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [49] Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin-17 Inhibitors: A Nationwide Population-Based Study Using the French National Health Data System
    Penso, Laetitia
    Bergqvist, Christina
    Meyer, Antoine
    Herlemont, Philippe
    Weill, Alain
    Zureik, Mahmoud
    Dray-Spira, Rosemary
    Sbidian, Emilie
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (02) : 244 - 252